Anbio Biotechnology (NNNN) is a in vitro & in vivo diagnostic substances company incorporated in Cayman Islands, listed on the Nasdaq. With a market capitalization of $1.0 billion, Anbio Biotechnology is a small-cap company. The stock currently trades at $22.91, down 11.06% today, with a 52-week range of $5.89–$55.65. The company trades at a trailing P/E of 381.8x.
No 10-K filings found.